Davita Inc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Davita Inc trades at $179.24 (market cap $11.29B), while Direxion Daily Semiconductor Bull 3X Shares trades at $137.96 (market cap $24.42B). The key difference: Direxion Daily Semiconductor Bull 3X Shares is far larger — about 2.2× Davita Inc's market cap, and Davita Inc is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Direxion Daily Semiconductor Bull 3X Shares for 15 Days on average.
| DVA | SOXL | |
|---|---|---|
Market Cap | $11.29B | $24.42B |
Volume | 582,204 | 100,232,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $240.96 | $300.77 |
52-Week Low | $103.87 | $30.81 |
Typical Hold Time | 113 Days | 15 Days |
Enterprise Value | $24.01B | — |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, with a bearish technical signal and neutral oscillators. The company shows strong earnings beats in recent quarters with Q2 2026 EPS of $4.02 beating expectations of $3.88. Revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026, though net margins have fluctuated. Recent partnership expansion with Humana for value-based kidney care represents significant business development.
DVA presents a mixed outlook with 43% analyst buy ratings and a $235.67 price target suggesting 33% upside. However, high debt levels (65.55% debt-to-asset ratio) and regulatory risks in healthcare weigh on fundamentals. The stock's current valuation at P/E 15 and P/S 0.88 appears reasonable relative to earnings growth potential, making it attractive for value investors despite near-term bearish technicals.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, trades at $141.3, down 11.08% with a bearish technical signal despite bullish moving averages. The semiconductor sector shows volatility with mixed news flow, ranging from strong AI demand to regulatory and tariff concerns. Recent price action reflects the leveraged ETF's sensitivity to chip stock movements, with support at $134 and resistance at $145.
Outlook remains cautious due to high leverage amplifying sector swings. Opportunities exist if semiconductor fundamentals strengthen, but risks include overcrowded trades and macroeconomic headwinds. Investors should weigh the ETF's structure against direct semiconductor exposure for risk management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →